Robert Orlowski, MD, PhD, professor of Medicine at The University of Texas MD Anderson Cancer Center, discusses prophylactic ...

As a small business owner, Liz understands the unique challenges entrepreneurs face. Well-versed in the digital landscape, she combines real-world experience in website design, building e-commerce ...

This guidance should be used alongside the following resources: Measles is highly infectious and has multiple differential ...

LINKER-MM4 trial shows linvoseltamab monotherapy achieves a 79% overall response rate in newly diagnosed MM patients, with 92 ...

Facing increasing need and limited domestic supply, Canadian Blood Services says it has never been more important to collect plasma in Canada than it is now.

Graham Holdings Company ( GHC) Analyst/Investor Day December 9, 2025 1:00 PM EST ...

As a writer for Forbes Home since 2021, Emily specializes in writing about home warranties, solar installations, car transportation and moving companies. With a background in journalism and experience ...

AvevoRx, a national, independent provider of specialty infusion pharmacy services, today announced significant growth in its in-home nursing program as the company continues investing in high-touch, ...

A notice on top of its website says "the well has run dry." The Department of Agriculture has posted a notice on its website warning that Supplemental Nutrition Assistance Program (SNAP) benefits ...

Miv-cel was well-tolerated, with no high-grade cytokine release syndrome (CRS) or immune effector cell-associated neurotoxicity syndrome (ICANS) observed. Grade 3/4 neutropenia, a known adverse event ...

Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to submit BLA for stiff person syndrome in 1H 2026 Miv-cel ...